Area of research
Psychiatry and Mental health · Biological Psychiatry
Research interest
Research interests include Schizophrenia (object-oriented programming), Clozapine, Medicine, Psychiatry, Transcranial magnetic stimulation, and Antipsychotic.
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN)
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them
Assessing the impact of sex on high-frequency repetitive transcranial magnetic stimulation´s clinical response in schizophrenia – results from a secondary analysis
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)
Exercise as an add-on treatment in individuals with schizophrenia: Results from a large multicenter randomized controlled trial
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
An international research agenda for clozapine-resistant schizophrenia
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia
Effects of high-frequency prefrontal rTMS on heart frequency rates and blood pressure in schizophrenia
Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia —Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine